| Antibiotic resistance and extended spectrum beta-lactamases: Types, epidemiology and treatment S Shaikh, J Fatima, S Shakil, SMD Rizvi, MA Kamal Saudi journal of biological sciences 22 (1), 90-101, 2015 | 342 | 2015 |
| A simple click by click protocol to perform docking: AutoDock 4.2 made easy for non-bioinformaticians SMD Rizvi, S Shakil, M Haneef EXCLI journal 12, 831, 2013 | 62 | 2013 |
| Risk factors for acquisition of extended spectrum beta lactamase producing Escherichia coli and Klebsiella pneumoniae in North-Indian hospitals S Shaikh, J Fatima, S Shakil, SMD Rizvi, MA Kamal Saudi journal of biological sciences 22 (1), 37-41, 2015 | 30 | 2015 |
| Prevalence of multidrug resistant and extended spectrum beta-lactamase producing Pseudomonas aeruginosa in a tertiary care hospital S Shaikh, J Fatima, S Shakil, SMD Rizvi, MA Kamal Saudi journal of biological sciences 22 (1), 62-64, 2015 | 29 | 2015 |
| Current acetylcholinesterase-inhibitors: A neuroinformatics perspective S Shaikh, A Verma, S Siddiqui, S S Ahmad, S MD Rizvi, S Shakil, ... CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2014 | 25 | 2014 |
| In-vitro antibacterial and antioxidant potential of leaf and flower extracts of Vernonia cinerea and their phytochemical constituents SMD Rizvi, D Biswas, JM Arif, M Zeeshan International Journal of Pharmaceutical Sciences Review and Research 9 (2 …, 2011 | 23 | 2011 |
| Invokana (Canagliflozin) as a dual inhibitor of Acetylcholinesterase and Sodium Glucose Co-Transporter 2: advancement in Alzheimer’s Disease-Diabetes Type 2 linkage via an … S MD Rizvi, S Shakil, D Biswas, S Shakil, S Shaikh, P Bagga, M A Kamal CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2014 | 22 | 2014 |
| Isolation, partial purification and evaluation of bioactive compounds from leaves of Ageratum houstonianum M Zeeshan, SMD Rizvi, MS Khan, A Kumar EXCLI journal 11, 78, 2012 | 20 | 2012 |
| A novel process for size controlled biosynthesis of gold nanoparticles using bromelain S Khan, SMD Rizvi, M Avaish, M Arshad, P Bagga, MS Khan Materials Letters 159, 373-376, 2015 | 15 | 2015 |
| Role of anti-diabetic drugs as therapeutic agents in Alzheimer's disease SMD Rizvi, S Shaikh, SMA Waseem, S Shakil, AM Abuzenadah, D Biswas, ... EXCLI journal 14, 684, 2015 | 15 | 2015 |
| Estimation of built-in voltage from steady-state current–voltage characteristics of organic diodes P Mantri, SMH Rizvi, B Mazhari Organic Electronics 14 (8), 2034-2038, 2013 | 15 | 2013 |
| Multiple targets for the management of Alzheimer’s disease S Sayeed Ahmad, S Akhtar, Q Mohammad Sajid Jamal, M A Kamal, ... CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2016 | 14 | 2016 |
| Molecular interaction of human brain acetylcholinesterase with a natural inhibitor Huperzine-B: An Enzoinformatics approach A Alam, S Shaikh, S S Ahmad, M A Ansari, S Shakil, S MD Rizvi, S Shakil, ... CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2014 | 14 | 2014 |
| Prediction of comparative inhibition efficiency for a novel natural ligand, Galangin against human brain Acetylcholinesterase, butyrylcholinesterase and 5-Lipoxygenase: a … S Shaikh, S S Ahmad, M A Ansari, S Shakil, S MD Rizvi, S Shakil, ... CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2014 | 13 | 2014 |
| Forxiga (dapagliflozin): Plausible role in the treatment of diabetes‐associated neurological disorders S Shaikh, SMD Rizvi, S Shakil, S Riyaz, D Biswas, R Jahan Biotechnology and applied biochemistry 63 (1), 145-150, 2016 | 12 | 2016 |
| Magnetic Nanoparticles: Properties, Synthesis and Biomedical Applications S Khan, SMD Rizvi, V Ahmad, M Hassan Baig, M Amjad Kamal, S Ahmad, ... Current drug metabolism 16 (8), 685-704, 2015 | 12 | 2015 |
| Magnetic Nanoparticles: Properties, Synthesis and Biomedical Applications KMS Khan S, Rizvi SM, Ahmad V, Baig MH, Kamal MA, Ahmad S, Rai M, Zafar ... Current Drug Metabolism 16 (8), 685-704, 2015 | 12 | 2015 |
| A neuroinformatics study describing molecular interaction of Cisplatin with acetylcholinesterase: a plausible cause for anticancer drug induced neurotoxicity M Hassan Baig, SM Danish Rizvi, S Shakil, M Amjad Kamal, S Khan CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2014 | 12 | 2014 |
| Kinetics and Molecular Docking Study of an Anti-diabetic Drug Glimepiride as Acetylcholinesterase Inhibitor: Implication for Alzheimer’s Disease-Diabetes Dual … SMD Rizvi, S Shaikh, D Naaz, S Shakil, A Ahmad, M Haneef, ... Neurochemical research 41 (6), 1475-1482, 2016 | 9 | 2016 |
| Fetzima (levomilnacipran), a drug for major depressive disorder as a dual inhibitor for human serotonin transporters and beta-site amyloid precursor protein cleaving enzyme-1 S Shaikh, M Khan, D Biswas, N Hameed, S Shakil CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2014 | 9 | 2014 |